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Lower extremity peripheral arterial disease
(PAD) is a common, chronic condition among older
men and women.1-3 Men and women with PAD
have poorer walking endurance and slower walking
speed than men and women without PAD.4 Most
investigators have used treadmill testing to assess
walking capacity in PAD.5 However, treadmill test-
ing may not necessarily reflect walking ability during
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Objectives: The Walking Impairment Questionnaire (WIQ) was designed to measure com-
munity walking ability in patients with peripheral arterial disease (PAD) and intermittent
claudication. We compared the WIQ scores to objective measures of walking in a hetero-
geneous group of patients with and without PAD.
Methods: The study was designed as a cross-sectional study, with the setting in an academ-
ic medical center. The subjects were patients with PAD (n = 145) who were identified
from a noninvasive vascular laboratory at an academic medical center. The patients with-
out PAD (n = 65) were identified from a general medicine practice. The average number
of comorbidities was 2.03 for patients with PAD and 1.52 for patients without PAD.
Among the patients with PAD, 28% had classical intermittent claudication symptoms and
55% had exertional leg symptoms other than claudication. The main outcome measures
were the WIQ estimates of the patient-reported walking distance and walking speed on a
scale of 0 to 100. Walking endurance was measured objectively with the 6-minute walk.
Walking velocity was measured with a 4-m walk. PAD and PAD severity were defined
with the ankle brachial index.
Results: The Spearman rank correlation coefficients (r ) between the WIQ distance score and
the 6-minute walk score were 0.557 among patients with PAD (P < .001) and 0.484 among
patients without PAD (P < .001). The correlation coefficients between the WIQ speed score
and the usual-paced 4-m walk score were 0.528 among patients with PAD (P < .001) and
0.524 among patients without PAD (P < .001). The correlations were not affected by the
presence versus the absence of intermittent claudication, by PAD severity, or by the presence
of 2 or more versus less than 2 comorbid illnesses. The WIQ scores in the highest and low-
est quartiles were the most closely associated with the objective measures of function.
Conclusion: The WIQ is a valid measure of community walking ability in a heterogeneous
group of patients with and without PAD. The WIQ discriminates best among patients in
the highest and the lowest quartiles of walking speed and endurance. (J Vasc Surg
1998;28:1072-81.)
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daily activities and may not be practical for some epi-
demiologic studies. Validated standardized measures
of patient-reported walking capability are needed for
large-scale studies that assess the natural history of
community walking ability and the effects of specif-
ic interventions on functioning in PAD.
The Walking Impairment Questionnaire (WIQ)
was developed for use as an independent measure
of patient-perceived walking performance for
patients with PAD and intermittent claudication.5,6
The WIQ estimates walking distance, walking
speed, and stair-climbing capacity in the communi-
ty. In a previous study of 26 patients with intermit-
tent claudication and no exercise-limiting comor-
bid diseases, the WIQ distance and speed scores
correlated with the peak treadmill walking time and
with the time to onset of intermittent claudication
on the treadmill.6 The WIQ walking distance and
walking speed scores are responsive to interven-
tions, such as lower-extremity revascularization and
exercise training in patients with intermittent clau-
dication.6-9
The primary aim of this study was the description
of the correlations in a heterogeneous cohort of
patients with PAD between the WIQ distance score
and the 6-minute walk score and between the WIQ
speed score and the 4-m walking velocity. The PAD
participants included patients with and without
intermittent claudication and patients with multiple
comorbid illnesses. The secondary aims were the
comparison of WIQ validity between the following:
the patients who had PAD with intermittent claudi-
cation versus without intermittent claudication, the
patients who had PAD with fewer than 2 comorbid
illnesses versus 2 or more comorbid illnesses, and the
patients who had PAD with mild to moderate dis-
ease versus severe disease. The results from the sec-
ondary specific aims will help determine whether the
WIQ has greater validity within specific subsets of
patients with PAD.
To our knowledge, previous studies have not
assessed the validity of the WIQ as a measure of
walking capability in a heterogeneous group of men
and women, including patients who had PAD with-
out intermittent claudication, patients who had PAD
with multiple comorbid illnesses, and general med-
ical patients without PAD. The validation of the
WIQ in a heterogeneous group of patients is impor-
tant because many patients with PAD have signifi-
cant comorbid illnesses and because the recent data
show that most men and women with PAD do not
have the typical symptoms of intermittent claudica-
tion.2,10,11
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METHODS
Subject identification and selection. The study
protocol was approved by the Institutional Review
Board. Consecutive patients aged 55 years and older
who were diagnosed with PAD in the noninvasive
vascular laboratory at Northwestern Memorial
Hospital between January 1, 1996, and approxi-
mately November 1, 1996, were identified with com-
puterized records. For a short time, the patients with
PAD were recruited with the random selection of
patients in our vascular surgery practice who had an
ICD-9 code that was consistent with lower-extremi-
ty PAD. The patients without PAD were identified
from among randomly selected men and women
aged 55 years and older with appointments in gener-
al internal medicine at Northwestern Medical Faculty
Foundation. The identified patients were mailed an
informational letter, were telephoned within 2 to 4
weeks after the mailing, and were invited to return to
the medical center for a study visit.
Inclusion criteria. The patients with PAD were
men and women with an ankle brachial index of less
than 0.90 at the time of their study visit. The
patients without PAD were men and women with an
ankle brachial index of ‡ 0.90 and <1.50.
Exclusion criteria. The following were exclu-
sion criteria: 1, a Mini-Mental Status Examination
score of less than 18 of 30 (n = 6)12; 2, nursing
home residence (n = 7); 3, dependence on a wheel-
chair (n = 15); 4, foot or lower-extremity amputa-
tion (n = 25); 5, lower-extremity ulcers (n = 4); 6,
the inability to communicate in English (n = 15);
and 7, a life expectancy of less than 6 months (n =
24). These exclusion criteria were chosen because
they would have interfered with the ability to obtain
an accurate history or would have reduced the like-
lihood of follow-up or because they indicated
extreme functional impairment. The patients who
did not complete the WIQ were excluded, and the
patients who completed neither the 6-minute walk
nor the 4-m walks were excluded.
Walking Impairment Questionnaire. The full
WIQ (Appendix) measures an individuals walking
endurance (WIQ distance score), walking speed
(WIQ speed score) and stair-climbing ability in the
community (WIQ stair-climbing score).6 The WIQ
was developed to be administered by study investiga-
tors and requires approximately 5 minutes to com-
plete. In the present study, the WIQ was mailed to the
patients before their study visit. The study participants
were asked to bring the completed questionnaire with
them to their study visit, at which time the investiga-
tors reviewed the questionnaire for completeness.
In the WIQ distance score, the degree of diffi-
culty in the walking of specific distances is ranked on
a 0 to 4 Likert scale, in which 0 represents the inabil-
ity to walk the distance and 4 represents no difficul-
ty. A Likert scale is an ordinal scale of consecutive,
equidistant, numerical values (ie, 0 to 4). The dis-
tances that are assessed in the WIQ range from walk-
ing indoors around the home to walking 5 blocks
(1500 feet). In the walking speed component, the
degree of difficulty walking is ranked on a 0 to 4
scale where speed is assessed for each of the follow-
ing speeds: at the following speeds: 1, slowly; 2,
average speed; 3, quickly; or 4, running or jogging
1 block. Zero represents the inability to walk the
specified speed, and 4 represents no difficulty.
Scoring the Walking Impairment Question-
naire. For the WIQ distance score, each distance,
expressed in feet, is multiplied by the Likert score
that was selected for that distance. The products are
summed and divided by the maximum possible score
to obtain the percent score. For the WIQ speed
score, each speed is given a “weight,” which ranges
from 1 mile per hour to 5 miles per hour and is mul-
tiplied by the corresponding Likert scale response.
The products are summed and divided by the maxi-
mum possible score to obtain the WIQ speed score.
Ankle brachial index and intermittent claudi-
cation measurements. The ankle brachial index was
measured on all patients with previously described
methods.2 Because the artery with the greatest
obstruction was expected to have the greatest effect
on the lower-extremity functioning, the lowest of the
dorsalis pedis and posterior tibial vessels was used to
calculate the ankle brachial index for each leg. The
lowest leg ankle brachial index measurement was
used in the analyses. The San Diego intermittent
claudication questionnaire identified the patients
with intermittent claudication,11 which was defined
as exertional calf symptoms that do not begin at rest,
that worsen when walking uphill or when hurrying,
and that resolve within 10 minutes of rest.
Six-minute walk and 4-m walks. The 6-
minute walk predicts the mortality rate among the
patients with congestive heart failure and predicts
the maximal oxygen consumption rate among the
patients with pulmonary disease.13-17 Among the
patients with intermittent claudication, the 6-minute
walk performance correlates with the objectively
measured physical activity levels.18 The subjects walk
up and down a 100-ft hallway for 6 minutes and are
encouraged to complete as many laps as possible.14
The distance that is achieved at the end of the 6 min-
utes is recorded. The 6-minute walk was added to
the protocol 3 months after the data collection
began and was performed for 126 patients with PAD
and for 47 patients without PAD. The patients were
timed walking a 4-m distance at their “usual” and
“fastest” paces.19 Among the patients with PAD, the
ankle brachial index level independently predicts the
4-m walking velocity.4
Comorbidity ascertainment. With algorithms
that were developed in the Women’s Health and
Aging Study, we combined the data from a medical
record review, a primary care physician question-
naire, medications, and a patient self-report to ascer-
tain and verify the comorbid diseases.20 The comor-
bidities were those that were shown to affect func-
tioning in previous epidemiologic studies and
consisted of angina, spinal disk disease, hip or knee
arthritis, congestive heart failure, diabetes mellitus,
hip fracture, myocardial infarction, pulmonary dis-
ease, Parkinson’s disease, stroke, and spinal stenosis.
A previous study that validated the WIQ exclud-
ed the patients who had PAD with exercise-limiting
comorbid diseases.6 To compare the validity of the
WIQ between the patients with varying numbers of
comorbid diseases, the patients were categorized
into 1 of 2 groups—those patients with no or 1
comorbid disease and those patients with 2 or more
comorbid illnesses.
Statistical analyses. The Spearman rank correla-
tion coefficients were used to assess the relationship
between the WIQ distance score and the 6-minute
walk performance score and to describe the relation-
ships between the WIQ speed score and the usual-
paced and fast-paced 4-m walking velocities.
Additional analyses were performed to determine
whether the WIQ scores correlated more strongly
with the objective measures of functioning in the spe-
cific subgroups of patients. For these comparisons,
multiple linear regression analyses were used to com-
pare the associations between the WIQ distance and
the speed scores and between the corresponding
objective measures of walking endurance and the
walking speed. The objective measures of function-
ing were dependent variables. Comparisons were
made between the following: 1, patients who had
PAD with intermittent claudication versus without
intermittent claudication; 2, patients with ankle
brachial indices of <0.40 versus patients with ankle
brachial indices of 0.40 to <0.90 versus patients with
ankle brachial indices of 0.90 to 1.50; and 3, patients
who had PAD with 2 or more comorbid illnesses ver-
sus with fewer than 2 comorbid illnesses. The latter 2
comparisons were made irrespective of intermittent
claudication symptoms. The interactions between
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these categories and the WIQ scores were examined
for their relationships with the objective measures of
functioning. For each comparison, an indicator vari-
able to separate each group and the cross product
term between the indicator variable and the WIQ
score were included in the model to compare the
slopes between the groups in each analysis. For each
comparison, the reference group was rotated and the
analyses were repeated to obtain the P values for each
reference category within the comparisons.
RESULTS
Of the 485 patients with PAD who were eligible by
age and who were identified during 1996, 74 met 1 or
more of the exclusion criteria. In addition, 274
patients either were deceased (n = 23), could not be
reached (n = 61), refused participation (n = 82), were
limited in transportation (n = 37), could not be sched-
uled during the enrollment period (n = 42), or did not
attend their scheduled appointment (n = 29), which
left 137 patients with PAD. An additional 21 patients
with PAD were identified from among the general
medicine participants with ankle brachial indices of
<0.90, and 7 were selected randomly from among the
patients visiting the vascular surgery practice in 1996.
Of all of the subjects with PAD, 18 did not complete
the WIQ and 1 did not complete the 6-minute walk or
the 4-m walks, which left 146 PAD subjects.
Of the 162 randomly selected men and women
from general medicine without ankle brachial indices
of <0.90, 42 met exclusion criteria, 35 refused par-
ticipation, 10 could not be reached, 1 was deceased,
4 did not attend scheduled appointments, and 2 did
not complete the 6-minute or the 4-m walks, which
yielded 68 patients. Completed WIQ forms were
not received from 3 patients, which yielded 65
patients without PAD.
Patient characteristics. Table I shows the char-
acteristics of the patients with PAD and of the
patients in the control group. Of the patients with
PAD and without PAD, 62% and 49%, respectively,
had 1 or more comorbid illnesses (P = .08). 
Bivariate correlations. Table I shows the aver-
age values and the standard deviations for the WIQ
scores and the objective measures of functioning.
The distance that was achieved in the 6-minute walk
correlated significantly with the WIQ distance scores
among the patients with PAD, the patients without
PAD, and all of the patients combined, (Table I).
Similar correlations were observed between the
WIQ speed scores and the usual-paced and fast-
paced 4-m walking velocities.
Fig 1 shows the percentage of all patients and of
the patients with PAD who fell into the first, second,
third, and fourth quartiles of both the WIQ distance
score and the 6-minute walk. Approximately half of
Fig 1. Percent of study patients in same quartile for Walking Impairment Questionnaire dis-
tance score and 6-minute walk.
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the patients without PAD had WIQ distance scores
of 100, which made meaningful comparisons
between the WIQ distance score and the 6-minute
walk quartiles difficult. The first set of bars shows
the proportion of all patients and the patients with
PAD whose WIQ distance score and 6-minute walk
performance were both within the first (lowest)
quartile of the results for all patients and patients
with PAD. The second set of bars shows the pro-
portion of all patients and patients with PAD whose
WIQ distance score and 6-minute walk performance
were both within the second quartile. Fig 2 shows
these associations for the WIQ speed score and the
usual-paced 4-m walk for all patients, patients with
PAD, and patients without PAD. The agreement
between the quartiles of each WIQ score and the
corresponding objective measurement was the high-
est for the patients in the first (lowest) and fourth
(highest) quartiles of the WIQ distance and the
WIQ speed scores. Of all the patients in the first
(slowest) quartile of the WIQ distance score, 83%
were in the first (slowest) or second (second-slow-
est) quartiles of the 6-minute walk. Of all the
patients in the fastest quartile of the WIQ distance
score, 83% were in the fastest or second-fastest quar-
tiles of the 6-minute walk. Similar relationships were
observed for the WIQ speed score. These data sug-
gest that the WIQ scores most accurately reflect the
objective measures of walking endurance and walk-
ing speed for patients with the poorest and best
walking endurance and for patients with the slowest
and fastest walking speeds.
WIQ correlations in men and women without
intermittent claudication. The results of multiple
linear regression show that, among the patients who
had PAD with intermittent claudication, each
Table I. Patient characteristics and correlations between Walking Impairment Questionnaire scores and
objective measures of functioning among men and women aged 55 years and older
Patients with PAD Patients in control group All patients
Characteristics (ABI, <0.90)(n = 146) (ABI, 0.90 to <1.50)(n = 65) (ABI, <1.50)(n = 211)
Age (years)* 71.7 ± 9.8 67.9 ± 7.7 70.5 ± 9.4
Female sex 44.5% 46.2% 45.0%
ABI* 0.56 ± 0.20 1.06 ± 0.08 0.72 ± 29
Black race 17.1% 15.4% 16.6%
Number of comorbidities 2.03 ± 1.42 1.52 ± 1.42 1.87 ± 1.44
Diabetes mellitus* 28.1% 10.8% 22.7%
Heart failure* 15.8% 6.2% 12.8%
Myocardial infarction 21.2% 16.8% 19.9%
Angina* 29.5% 18.5% 26.1%
Previous lower-extremity revascularization* 37.7% 7.7% 28.4%
Leg symptoms*
No exertional leg pain 16.4% 76.9% 35.1%
Intermittent claudication 28.1% 3.1% 20.4%
Leg symptoms other than claudication 55.5% 20.0% 44.5%
Claudication severity (0 to 5 scale, 2.13 3.24 2.47
where 0 is worst score)*
Measurements
WIQ distance score (0 to 100 scale)† 40.99 ± 30.74 78.97 ± 31.36 52.69 ± 35.51
WIQ speed score (0 to 100 scale)† 37.10 ± 26.70 63.89 ± 29.46 45.26 ± 30.20
WIQ stair-climbing score (0 to 100 scale)* 48.98 ± 29.6 70.13 ± 30.0 55.59 ± 31.2
6-minute walk (feet)† 1160 ± 365 1608 ± 340 1281 ± 410
Usual-paced 4-m walk (m/s)† 0.96 ± 0.28 1.09 ± 0.24 1.00 ± 0.28
Fast-paced 4-m walk (m/s)† 1.31 ± 0.42 1.49 ± 0.34 1.37 ± 0.40
Spearman rank correlation coefficients 
between WIQ scores and objective 
walking measures
WIQ distance score and 6-minute walk† 0.557 0.484 0.665
WIQ speed score and usual-paced 4-m walk† 0.528 0.524 0.586
WIQ speed score and fast-paced 4-m walk† 0.56 0.515 0.593
PAD, Peripheral arterial disease; ABI, ankle brachial index; WIQ, Walking Impairment Questionnaire.
*P < .05 for comparisons between patients with and without peripheral arterial disease.
†Significant at P < .001.
For the 6-minute walk outcome only, data were available for 173 study patients (47 patients in the control group and 126 patients with
peripheral arterial disease). 
Claudication severity was assessed by asking, “In the last week, how much difficulty did you have walking because of pain, aching, or
cramps in the calves?”
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increase of 10 units in WIQ distance score was asso-
ciated with an additional 68.7 ft achieved in the 6-
minute walk (Table II). Among the patients who
had PAD without intermittent claudication, the rela-
tionship between the WIQ distance score and the 6-
minute walk was nearly identical to that reported for
the patients who had PAD with intermittent claudi-
cation. For the patients who had PAD with inter-
mittent claudication, each increase of 10 units in the
WIQ distance score was associated with an increase
of 0.046 m/s and 0.069 m/s in the usual-paced and
fast-paced 4-m walks, respectively. As shown in
Table II, the coefficients for the WIQ speed scores
as predictors of usual and fastest 4-m walking veloc-
ities were slightly larger among the patients who had
PAD without intermittent claudication than among
the patients who had PAD with intermittent claudi-
cation, but the interaction term was not significant. 
Walking Impairment Questionnaire correla-
tions according to ankle brachial index category
and number of comorbid illnesses. The relation-
ships between the WIQ distance score and the 6-
minute walk performance were not significantly dif-
ferent between the patients with severe PAD, mild-
to-moderate PAD, and no PAD (Table III). Similarly,
the associations between the WIQ walking speed
scores and the 4-m walking velocities did not differ
by PAD severity. As shown in Table IV, the associa-
tions between the WIQ scores and the objective mea-
sures of functioning did not significantly differ
between the patients who had PAD with 2 or more
comorbid diseases versus those with fewer than 2
comorbid diseases.
DISCUSSION
The development of valid instruments for esti-
mating walking velocity and walking endurance is
important for researchers when it is impractical or
impossible to objectively measure walking speed and
endurance. The WIQ is a brief, simple measure of
patient-reported walking ability that may be practi-
cal in large-scale epidemiologic studies and in the
clinical setting. In a previous study that validated the
WIQ, patients who had PAD without intermittent
claudication and patients who had PAD with severe
comorbid illnesses that limited exercise capacity
were excluded.6 Because most patients with PAD do
not have the typical symptoms of intermittent clau-
dication1,2,10,11 and because many patients with
PAD have significant comorbid illnesses,22 the
results from the previous studies may not be gener-
alizable to the majority of patients with PAD who do
Fig 2. Percent of study patients in same quartile for Walking Impairment Questionnaire speed
score and regular-paced 4-m walking velocity.
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not have intermittent claudication or significant
comorbid disease. 
Summary of findings. Our data suggest that
the WIQ is a useful measure of walking endurance
and walking speed in a diverse group of patients with
PAD and in general medical patients without PAD.
The WIQ distance score was highly correlated with
the objectively measured walking endurance, as mea-
sured with the 6-minute walk. The WIQ speed score
correlated highly with the objectively measured walk-
ing velocity. These correlations did not significantly
differ between the patients with PAD and the gener-
al medical patients, between the patients with PAD
with intermittent claudication versus those without
intermittent claudication, or between the patients
with PAD with fewer than 2 comorbid illnesses ver-
sus 2 or more comorbid illnesses. However, our data
show that the WIQ distance and speed scores most
accurately reflect the objective measures of function-
ing among the patients with the lowest and highest
Table III. Multiple linear regression of objective measures of functioning on Walking Impairment
Questionnaire scores among men and women with peripheral arterial disease by disease severity*
ABI category Regression coefficient† P value P value for comparison between groups‡
6-minute walk on WIQ (feet)
ABI, 0.90 to 1.50 6.73 <.001 —
ABI, 0.40 to <0.90 7.41 <.001 .65
ABI, <0.40 5.93 .03 .86
Regular-paced 4-m walk on WIQ speed score (m/s)
ABI, 0.90 to 1.50 0.0046 <.001 —
ABI, 0.40 to <0.90 0.0058 <.001 .37
ABI, <0.40 0.0023 .23 .28
Fast-paced 4-m walk (m/s) on WIQ speed score
ABI, 0.90 to 1.50 0.0067 <.001 —
ABI, 0.40 to <0.90 0.0095 <.001 .23
ABI, <0.40 0.0049 .081 .57
ABI, Ankle brachial index; WIQ, Walking Impairment Questionnaire.
*Two indicator variable to separate the 3 groups (patients with ankle brachial index 0.90 to 1.50, patients with ankle brachial index 0.40
to 0.90, and patients with ankle brachial index <0.4) and the cross product terms between the indicator variable and the WIQ score were
included in the model to compare slopes between the 3 groups. An additional analysis was performed to obtain the P value that corre-
sponded to the regression coefficient for the reference peripheral arterial disease group.
†Results are reported per 10 Walking Impairment Questionnaire score units. 
‡P value for comparison of slope between the 3 groups. This comparison was performed with the indicator variable and the cross prod-
uct term of the indicator variable and the Walking Impairment Questionnaire score. 
Table II. Multiple linear regression of objective measures of functioning on Walking Impairment
Questionnaire scores among men and women with peripheral arterial disease by presence of intermittent
claudication symptoms*
Regression coefficient† P value P value for interaction term‡
6-minute walk on WIQ (feet)
PAD with intermittent claudication 68.7 <.001 —
PAD unassociated with intermittent claudication 67.7 <.001 .965
Regular-paced 4-m walk on WIQ speed score (m/s)
PAD with intermittent claudication 0.046 <.001 —
PAD unassociated with intermittent claudication 0.058 <.001 .5
Fast-paced 4-m walk on WIQ speed score (m/s)
PAD with intermittent claudication 0.069 <.001 —
PAD unassociated with intermittent claudication 0.093 <.001 .35
WIQ, Walking Impairment Questionnaire; PAD, peripheral arterial disease.
*An indicator variable to separate the 2 peripheral arterial disease groups (patients with intermittent claudication and patients without
intermittent claudication) and the cross product term between the indicator variable and the Walking Impairment Questionnaire score
were included in the model to compare the slope between the 2 peripheral arterial disease groups. An additional analysis was performed
to obtain the P value that corresponded to the regression coefficient for the reference peripheral arterial disease group.
†Results are reported per 10 Walking Impairment Questionnaire score units. 
‡P value for comparison of slope between the 2 peripheral arterial disease groups. This comparison was performed with the indicator
variable and the cross product term of the indicator variable and Walking Impairment Questionnaire score. 
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WIQ distance and speed scores. In our population,
the WIQ distance score was the most accurate for the
patients with WIQ distance scores between 0 and 19
or between 89 and 100. The WIQ speed score was
the most accurate for patients with WIQ speed scores
between 0 and 18 or between 67 and 100. 
Our results show that the correlation between the
WIQ and the objective measures of walking is not
perfect. This lack of perfect correlation most likely
reflects the WIQ’s sensitivity to the patients’ percep-
tions of their walking endurance and speed. The
patient-specific factors, such as depressed mood and
perception of optimal walking speed and endurance,
are likely to affect the responses to the WIQ.
Previous work on the Walking Impairment
Questionnaire. In a previous study of patients with
intermittent claudication, Regensteiner et al6 assessed
the correlation between the WIQ distance and speed
scores and the treadmill walking time among 26
patients with intermittent claudication who under-
went either lower-extremity revascularization, exercise,
or no intervention. The patients with exercise-limiting
comorbid diseases, such as angina, heart failure, chron-
ic obstructive pulmonary disease, or arthritis, were
excluded. Among all of the claudication patients, the
peak treadmill walking time correlated with the WIQ
distance score (Pearson coefficient = 0.58; P < .05)
and the WIQ speed score (Pearson coefficient = 0.67;
P < .05). The WIQ speed and distance scores also cor-
related with the time to onset of claudication on the
treadmill.6 The correlation coefficients that were
obtained by Regensteiner et al6 are comparable with
those that are reported here for a more diverse group
of patients with PAD and for patients without PAD.
Our work reported here adds to the previous data in
the following ways: 1, by validating the WIQ distance
and speed scores in a larger and more heterogeneous
group of patients with PAD; 2, by validating the WIQ
scores among the general medical patients; and 3, by
validating the WIQ speed score against the objectively
measured walking velocity.
Study limitations. A large proportion of identi-
fied patients with and without PAD in our study
refused or were unable to participate. Additional data
that were collected from potentially eligible patients
with PAD who declined study participation show
that the average ankle brachial index of the partici-
pating patients with PAD from the noninvasive vas-
cular laboratory was 0.55 as compared with 0.54 for
a 50% randomly selected subset of patients with PAD
from the noninvasive vascular laboratory who were
potentially eligible but did not participate. The aver-
age age of the participating patients with PAD from
the vascular laboratory was 72 years, and 43% of the
patients were women, as compared to 75 years and
54% women for the non-participating patients with
PAD from the noninvasive vascular laboratory. These
data suggest that the participating patients with PAD
are reasonably comparable with the non-participants
with PAD who were identified from the noninvasive
vascular laboratory. Nonetheless, we cannot be cer-
tain that these relationships would have been similar
among the potentially eligible non-participants. 
Although the WIQ scores were not validated
Table IV. Multiple linear regression of objective measures of functioning on Walking Impairment
Questionnaire scores among men and women with peripheral arterial disease by presence of comorbid ill-
ness*
Regression coefficient† P value P value for interaction term‡
6-minute walk on WIQ (feet)
PAD and fewer than 2 comorbid diseases 6.042 <.001 —
PAD and 2 or more comorbidities 6.739 <.001 .512
Regular-paced 4-m walk (m/s) on WIQ speed score
PAD and fewer than 2 comorbid diseases 0.005 <.001 —
PAD and 2 or more comorbidities 0.006 <.001 .765
Fast-paced 4-m walk (m/s) on WIQ speed score
PAD and fewer than 2 comorbid diseases 0.007 .002 —
PAD and 2 or more comorbidities 0.009 <.001 .422
WIQ, Walking Impairment Questionnaire; PAD, peripheral arterial disease.
*An indicator variable to separate the 2 peripheral arterial disease groups (patients with 0 or 1 comorbid illnesses and patients with 2 or
more comorbid illnesses) and the cross product term between the indicator variable and the Walking Impairment Questionnaire score
were included in the model to compare the slope between the 2 peripheral arterial disease groups. An additional analysis was performed
to obtain the P value that corresponded to the regression coefficient for the reference peripheral arterial disease group.
†Results are reported per 10 Walking Impairment Questionnaire score units. 
‡P value for comparison of slope between the 2 peripheral arterial disease groups. This comparison was performed with the indicator
variable and the cross product term of the indicator variable and the Walking Impairment Questionnaire score.
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against the treadmill testing in this study, the 4-m
walk and the 6-minute walk are both objective mea-
sures of functioning that have been validated previ-
ously.16-22 Recent studies have validated the 6-
minute walk and the 4-m walks among patients with
PAD.4,18
CONCLUSION
These data suggest that the WIQ is a meaningful
tool with which to estimate the walking ability in
PAD and general medical patients with or without
significant comorbid illness and with or without
intermittent claudication. These data may be helpful
to investigators conducting large scale studies in
which the objective measurement of walking veloci-
ty and walking endurance is impractical. The WIQ
may be a useful measure of walking in other popula-
tions without PAD, such as patients with arthritis or
patients who undergo orthopedic procedures. The
WIQ also may be a useful tool for the assessment of
walking ability by clinicians. Further study is neces-
sary to determine whether the WIQ scores can be
used to predict important outcomes, such as mobil-
ity loss or the progression of PAD to rest pain and
gangrene. 
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APPENDIX. WALKING IMPAIRMENT QUESTIONNAIRE
Walking distance: Report the degree of physical difficulty that best describes how hard it was for you to
walk on level ground without stopping to rest for each of the following distances during the last week:
Degree of difficulty
Distance None Slight Some Much Unable
1. Walking indoors 
(ie, around the home) 4 3 2 1 0
2. Walking 50 feet? 4 3 2 1 0
3. Walking 150 feet? 
(1/2 block) 4 3 2 1 0
4. Walking 300 feet?
(1 block) 4 3 2 1 0
5. Walking 600 feet?
(2 blocks) 4 3 2 1 0
6. Walking 900 feet?
(3 blocks) 4 3 2 1 0
7. Walking 1500 feet?
(5 blocks) 4 3 2 1 0
Walking speed: Report the degree of physical difficulty that best describes how hard it was for you to walk
one city block on level ground at each of these speeds without stopping to rest during the last week:
Degree of difficulty
Stairs None Slight Some Much Unable
1. Walking 1 block slowly? 4 3 2 1 0
2. Walking 1 block at an average speed? 4 3 2 1 0
3. Walking 1 block quickly? 4 3 2 1 0
4. Running or jogging 1 block? 4 3 2 1 0
Stair climbing: For each of these questions, report the degree of physical difficulty that best describes how
hard it was for you to climb stairs without stopping to rest during the past week:
Degree of difficulty
Stairs None Slight Some Much Unable
1. Climbing 1 flight of stairs 4 3 2 1 0
2. Climbing 2 flights of stairs 4 3 2 1 0
3. Climbing 3 flights of stairs 4 3 2 1 0
